Dyadic International Inc DYAI Q1 2026 Earnings Wider Loss as RD Investment Accelerates Stock Rises on Pipeline Hope LGL Q1 2026 Earnings Loss Per Share Disappoints Amid Missing Revenue Data PROK Q1 2026 Earnings NarrowerThanExpected Loss as Clinical Development Continues Box Q1 2026 Earnings Strong EPS Beat Drives Positive Momentum PALI Q1 2026 Earnings WiderthanExpected Loss Highlights PreRevenue Biotech Challenges Acrivon Therapeutics Q1 2026 Earnings Narrowerthanexpected loss as clinical development progresses